ResearcherCentre Hospitalier Universitaire VaudoisNo recent work listed

Aimable Nahimana

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4968-3167; OpenAlex author ID A5029754927. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alessio Nencioni · 2 shared papers, 2018–2022 · strength 0.19
- Paper Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114504 ↗
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗
Faustino Mollinedo · 2 shared papers, 2018–2022 · strength 0.19
- Paper Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114504 ↗
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗
Pierre Vogel · 2 shared papers, 2018–2022 · strength 0.19
- Paper Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114504 ↗
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗
Jian‐Fei Bai · 2 shared papers, 2018–2022 · strength 0.19
- Paper Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114504 ↗
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗
Consuelo Gajate · 2 shared papers, 2018–2022 · strength 0.19
- Paper Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114504 ↗
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗
Caroline S. Breton · 2 shared papers, 2015–2018 · strength 0.12
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗
- Paper Combinative effects of β-Lapachone and APO866 on pancreatic cancer cell death through reactive oxygen species productio… DOI 10.1016/j.biochi.2015.07.012 ↗
Sophie Poty · 1 shared paper, 2022 · strength 0.12
- Paper Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114504 ↗
Claudia Bello · 1 shared paper, 2018 · strength 0.07
- Paper Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells. DOI 10.1016/j.ejmech.2018.02.086 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.